Levalbuterol (Xopenex)

11/01/2007 - "Levalbuterol HFA MDI when administered before exercise was effective in protecting adults with asthma from EIB."
12/01/2005 - "Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma."
09/01/2006 - "Levalbuterol was evaluated in several recent trials for treatment of asthma in the emergency department, for its effect in improving pulmonary function and on hospitalization rate. "
12/01/2005 - "In this study of levalbuterol in children aged 2-5 years with asthma, LEV was generally well-tolerated, and in children able to perform PEF, led to significant bronchodilation compared with placebo."
04/01/2021 - "In this work we carried out a screening of a compound library with 1280 approved drugs and we identified levalbuterol, a beta2-adrenergic agonist that is broadly used in asthma treatment, as an interesting validated binder of human TH. "

08/01/2006 - "In this study, levalbuterol treatment in subjects with COPD was generally well tolerated, produced significant bronchodilation compared with PBO, and improved clinical control of COPD as evidenced by reductions in rescue medication use compared with PBO and/or RAC."
08/01/2006 - "The efficacy and safety of nebulized levalbuterol in adults with chronic obstructive pulmonary disease (COPD) was evaluated in this multicenter, randomized, double-blind, parallel design study. "
01/01/2022 - "Levalbuterol is a cost-saving option for treating hospitalized patients with COPD in China. "
08/01/2006 - "Evaluation of the efficacy and safety of levalbuterol in subjects with COPD."
09/01/2003 - "To evaluate the effectiveness of a single dose of nebulized levalbuterol in COPD. "

07/01/2016 - "Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction."
07/01/2016 - "To determine the dose at which inhaled levalbuterol produces maximal bronchodilatory effect (EDmax) and determine its duration of action in recurrent airway obstruction (RAO)-affected horses in comparison to racemic albuterol. "

08/01/2009 - "High-dose continuous nebulized levalbuterol for pediatric status asthmaticus: a randomized trial."
08/01/2009 - "To assess the use of high-dose continuous levalbuterol (LEV), the single active (R)-enantiomer of racemic albuterol (RAC), in the treatment of status asthmaticus. "
05/01/2012 - "Acute severe asthma, formerly known as status asthmaticus, is defined as severe asthma unresponsive to repeated courses of beta-agonist therapy such as inhaled albuterol, levalbuterol, or subcutaneous epinephrine. "

09/01/2002 - "This study was performed to determine if levalbuterol improves dyspnea as assessed by prehospital clinical parameters. "
04/01/2009 - "Changes in pulmonary function, dyspnea, and rescue levalbuterol use were evaluated, as were safety outcomes. "